A0A0B4J279 (TVA21_HUMAN) Homo sapiens (Human)
T cell receptor alpha variable 21 UniProtKBInterProInteractive Modelling
112 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
9 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Structural and kinetic basis for heightened immunogenicity of T cell vaccines |
Heteromer A0A0K0K1A5; P01848; P01850; | |||||
| Assess | ||||||
| Structural and kinetic basis for heightened immunogenicity of T cell vaccines |
Heteromer A0A0K0K1A5; P01848; P01850; P04439; P61769; P78358; | |||||
| Assess | ||||||
| Structural and kinetic basis for heightened immunogenicity of T cell vaccines |
Heteromer A0A0K0K1A5; P01848; P01850; P04439; P61769; P78358; | |||||
| Assess | ||||||
| HLA Class I antigen |
Heteromer A0A592; A0A5B9; P01848; P04439; P40967; P61769; | 10×EDO; 3×GOL; 8×SO4; | ||||
| Assess | ||||||
| MAGE-A3 Reactive TCR in complex with Titin Epitope in HLA-A1 |
Heteromer A0A578; A0A5B9; P01848; P04439; P61769; Q8WZ42; | 1×GOL; 11×SO4; | ||||
| Assess | ||||||
| Engineered Human HLA_A2 MHC Class I molecule in complex with TCR and SV9 peptide |
Heteromer A0A0K0K1A5; K7N5M4; K7N5N2; P04439; P61769; | 1×GOL; 1×ACT; | ||||
| Assess | ||||||
| MAGE-A3 reactive TCR in complex with MAGE-A3 in HLA-A1 |
Heteromer A0A578; A0A5B9; P01848; P04439; P43357; P61769; | 7×SO4; | ||||
| Assess | ||||||
| Crystal structure of human TCR Alpha Chain-TRAV21-TRAJ8, Beta Chain-TRBV7-8, Antigen-presenting gly… |
Heteromer A0A5B9; P01848; P15813; P61769; | 2×NAG; 1×JLS; | ||||
| Assess | ||||||
| Crystal structure of human TCR Alpha Chain-TRAV21-TRAJ8 and Beta Chain-TRBV7-8 |
Heteromer A0A5B9; P01848; | |||||
| Assess | ||||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 3vxr.1.C | monomer | 0.88 | 100.00 | |||
| Assess | ||||||